RAPT Therapeutics, Inc. Earnings Per Share, Basic and Diluted
RAPT Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.69 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-11
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.69.
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.61.
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.63.
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.63.
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.53.
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.19.
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$9.89, a 117.03% decline from fiscal 2018.
- RAPT Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was $58.09.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.69 10-Q · filed 2022-05-11 | -$1.30 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$2.56 derived: net income ÷ weighted average shares · filed 2023-11-13 | |||
| 2021-12-31 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$1.24 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$1.87 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$2.53 10-K · filed 2022-03-10 | |||
| 2021-09-30 | -$0.63 10-Q · filed 2021-11-10 | -$1.26 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.92 10-Q · filed 2021-11-10 | -$2.45 derived: net income ÷ weighted average shares · filed 2022-11-10 | |||
| 2021-06-30 | -$0.63 10-Q · filed 2021-08-11 | -$1.29 10-Q · filed 2021-08-11 | -$1.81 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.41 derived: net income ÷ weighted average shares · filed 2022-11-10 | |||
| 2021-03-31 | -$0.66 10-Q · filed 2022-05-11 | -$1.18 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.78 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.29 derived: net income ÷ weighted average shares · filed 2022-11-10 | |||
| 2020-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.12 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.63 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$2.19 10-K · filed 2022-03-10 | |||
| 2020-09-30 | -$0.60 10-Q · filed 2021-11-10 | -$1.11 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.67 10-Q · filed 2021-11-10 | -$2.45 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2020-06-30 | -$0.51 10-Q · filed 2021-08-11 | -$1.08 10-Q · filed 2021-08-11 | -$1.85 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$3.07 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2020-03-31 | -$0.56 10-Q · filed 2021-05-11 | -$1.37 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$2.78 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$4.70 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2019-12-31 | -$0.87 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$2.90 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$6.08 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$9.89 10-K · filed 2021-03-11 | $9.89 10-K · filed 2020-03-30 | ||
| 2019-09-30 | -$12.41 10-Q · filed 2020-11-16 | $12.41 10-Q · filed 2019-12-11 | -$27.06 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$40.15 10-Q · filed 2020-11-16 | $40.15 10-Q · filed 2019-12-11 | -$53.59 derived: net income ÷ weighted average shares · filed 2020-11-16 | |
| 2019-06-30 | -$14.78 10-Q · filed 2020-08-13 | -$28.80 10-Q · filed 2020-08-13 | -$41.31 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$57.07 derived: net income ÷ weighted average shares · filed 2020-11-16 | |||
| 2019-03-31 | -$13.28 10-Q · filed 2020-05-14 | -$26.52 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$42.27 derived: net income ÷ weighted average shares · filed 2020-11-16 | ||||
| 2018-12-31 | -$13.24 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$29.01 derived: net income ÷ weighted average shares · filed 2020-03-30 | $58.09 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $15.90 10-Q · filed 2019-12-11 | $45.11 10-Q · filed 2019-12-11 |